or Try an Advanced Search...

    Technical Analysis for INTS - Intensity Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 3.18 2.42% 0.08
    INTS closed up 2.42 percent on Thursday, November 14, 2024, on 1.3 times normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical INTS trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Inside Day Range Contraction 0.00%
    Gapped Down Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Fell Below 20 DMA Bearish 2.42%
    Volume Surge Other 2.42%
    Wide Range Bar Range Expansion 2.42%
    Gapped Down Weakness 2.42%
    Lower Bollinger Band Touch Weakness 2.42%
    Older End-of-Day Signals for INTS ...

       Recent Intraday Alerts

    Alert Time
    1.5x Volume Pace about 12 hours ago
    Possible Inside Day about 12 hours ago
    20 DMA Resistance about 14 hours ago
    10 DMA Resistance about 14 hours ago
    Down 3% about 14 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    INTS Chart by TradingView
    Basic chart:

    Profile

    intensity therapeutics is a connecticut based biopharmaceutical company whose mission is to create safer and more efficacious chemotherapy treatments. intensity therapeutics is a preclinical, in vivo stage company seeking investors interested in helping to advance the company’s technology and products.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Pharmacy Chemotherapy

    Is INTS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 13 Intensity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
    Nov 13 3 US Penny Stocks With Market Caps Under $200M To Watch
    Nov 8 Intensity Therapeutics Selected for Oral Podium Presentation in a Late-Breaking Session at the 2024 Annual Connective Tissue Oncology Society (Sarcomas) Meeting
    Oct 31 Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Announce the First Patient Dosed in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 / SAKK 66/22)
    Aug 9 Intensity Therapeutics GAAP EPS of -$0.36
    Aug 8 Intensity Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
    Jul 9 Intensity Therapeutics, Inc. Announces First Patient Dosed in its Global Randomized, Phase 3 Study (INVINCIBLE-3) in Metastatic Soft Tissue Sarcoma
    Jun 6 Will Intensity Therapeutics (NASDAQ:INTS) Spend Its Cash Wisely?
    May 15 Intensity Therapeutics, Inc. Announces the Appointment of Thomas Dubin to Its Board of Directors
    May 14 Intensity Therapeutics: A Bargain For A Late-Stage Company With A Remarkable Oncology Drug
    See more INTS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.44
    52 Week Low 2.03
    Average Volume 13,833
    200-Day Moving Average 4.26
    50-Day Moving Average 3.57
    20-Day Moving Average 3.24
    10-Day Moving Average 3.23
    Average True Range 0.24
    RSI (14) 44.13
    ADX 42.54
    +DI 9.75
    -DI 24.15
    Chandelier Exit (Long, 3 ATRs) 2.72
    Chandelier Exit (Short, 3 ATRs) 3.52
    Upper Bollinger Bands 3.43
    Lower Bollinger Band 3.05
    Percent B (%b) 0.33
    BandWidth 11.53
    MACD Line -0.10
    MACD Signal Line -0.12
    MACD Histogram 0.0244
    Fundamentals Value
    Market Cap 43.53 Million
    Num Shares 13.7 Million
    EPS -0.74
    Price-to-Earnings (P/E) Ratio -4.29
    Price-to-Sales 0.00
    Price-to-Book 3.07
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.58
    Resistance 3 (R3) 3.57 3.42 3.51
    Resistance 2 (R2) 3.42 3.32 3.43 3.49
    Resistance 1 (R1) 3.30 3.25 3.36 3.31 3.47
    Pivot Point 3.15 3.15 3.18 3.16 3.15
    Support 1 (S1) 3.03 3.05 3.09 3.04 2.88
    Support 2 (S2) 2.88 2.98 2.89 2.86
    Support 3 (S3) 2.76 2.88 2.84
    Support 4 (S4) 2.77